Cimzia 2X200 MG/ML syringe kits
Ended Awarded
- Contract number
- SPE2DB25FEFFQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,305
Award facts
- Contract value 100% obligated
- $21,304.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,304.71 delivery order to AmerisourceBergen Drug Corp for Cimzia 2x200 mg/mL syringe kits, with an ultimate completion date of July 23, 2025. This contract represents a non-set-aside, competitively awarded delivery order using firm fixed pricing. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs worldwide.
This award reflects AmerisourceBergen Drug Corp's established role as a critical vendor within the Defense Logistics Agency's Medical Supply Chain, demonstrating the company's capability to fulfill federal procurement requirements through open competition. Cimzia, an immunosuppressant medication used in treating inflammatory conditions, is one of many specialized pharmaceutical products the company supplies through its DLA IDC to support defense healthcare operations. The competitively awarded delivery order structure, consistent with AmerisourceBergen Drug Corp's historical contract portfolio with DLA, enables flexible procurement of pharmaceutical commodities needed by the Defense Health Agency and other military healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FEFFQ?
SPE2DB25FEFFQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FEFFQ worth?
The government has obligated $21,305 on SPE2DB25FEFFQ.
Is contract SPE2DB25FEFFQ an order under another contract?
Yes. SPE2DB25FEFFQ is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEFFQ competed?
The extent of competition for SPE2DB25FEFFQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award